Cardinal Health Inc. (CAH)
NYSE: CAH
· Real-Time Price · USD
161.36
0.84 (0.52%)
At close: Jun 13, 2025, 3:59 PM
161.42
0.04%
After-hours: Jun 13, 2025, 07:51 PM EDT
Cardinal Health Revenue Breakdown
| Period Ending | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 | Jun 30, 2019 | Jun 30, 2018 | Jun 30, 2017 | Jun 30, 2016 | Jun 30, 2015 | Jun 30, 2014 | Jun 30, 2013 | Jun 30, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GMPD Revenue | 12.38B | 188.81B | 164.58B | 144.99B | 136.69B | 129.07B | 121.24B | 116.46B | 109.13B | 91.12B | 80.11B | 91.1B | 97.92B |
| GMPD Revenue Growth | -93.44% | +14.72% | +13.51% | +6.07% | +5.91% | +6.45% | +4.10% | +6.72% | +19.77% | +13.74% | -12.06% | -6.97% | n/a |
| Other Operating Segment Revenue | 4.51B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Operating Segment Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pharmaceutical Member Revenue | 210.02B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pharmaceutical Member Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 | Jun 30, 2019 | Jun 30, 2018 | Jun 30, 2017 | Jun 30, 2016 | Jun 30, 2015 | Jun 30, 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Us Revenue | 1.68B | 4.64B | 4.52B | 4.73B | 4.23B | 4.07B | 4.28B | 4.97B | 4.68B | 4.1B | 3.63B |
| Non-Us Revenue Growth | -63.76% | +2.56% | -4.32% | +11.70% | +3.95% | -4.95% | -13.82% | +6.15% | +14.31% | +12.68% | n/a |
| United States Revenue | 225.23B | 200.38B | 176.85B | 157.76B | 148.71B | 141.48B | 132.53B | 125.01B | 116.86B | 98.44B | 87.45B |
| United States Revenue Growth | +12.40% | +13.30% | +12.11% | +6.09% | +5.11% | +6.76% | +6.02% | +6.97% | +18.72% | +12.56% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 1.31B | 1.31B | 1.28B | 1.28B | 1.28B | 1.28B | 1.2B | 1.27B | 1.18B | 1.19B | 1.2B | 1.16B | 1.14B | 1.15B | 1.11B | 1.13B | 1.12B | 1.15B | 1.14B | 1.14B | 1.17B | 1.16B | 1.11B | 1.17B | 1.1B | 1.06B | 1.16B | 1.27B | 1.13B | 1.13B | 1.06B | 983M | 960M | 910M | 920M | 970M | 914M | 922M | 842M | 847M | 803M |
| Selling, General, and Administrative Revenue Growth | +0.69% | +2.27% | 0.00% | -0.39% | -0.08% | +7.18% | -5.52% | +7.46% | -1.01% | -0.50% | +3.64% | +1.58% | -1.22% | +3.32% | -1.33% | +0.80% | -2.35% | +0.88% | 0.00% | -2.40% | +0.17% | +5.06% | -5.22% | +6.47% | +3.10% | -7.88% | -9.06% | +12.19% | +0.09% | +6.50% | +8.04% | +2.40% | +5.49% | -1.09% | -5.15% | +6.13% | -0.87% | +9.50% | -0.59% | +5.48% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue | 1.31B | 1.31B | 1.28B | n/a | 1.28B | 1.28B | 1.2B | n/a | 1.18B | 1.19B | 1.2B | 1.16B | 1.14B | 1.15B | 1.11B | n/a | 1.12B | 1.15B | 1.14B | n/a | 1.17B | 1.16B | 1.11B | 3M | 1.1B | 1.06B | 1.16B | -1M | 1.13B | 1.13B | 1.06B | n/a | 960M | 910M | 920M | n/a | 914M | 922M | 842M | n/a | 803M |
| Sales and Marketing Revenue Growth | +0.69% | +2.27% | n/a | -100.00% | -0.08% | +7.18% | n/a | -100.00% | -1.01% | -0.50% | +3.64% | +1.58% | -1.22% | +3.32% | n/a | -100.00% | -2.35% | +0.88% | n/a | -100.00% | +0.17% | +5.06% | +36800.00% | -99.73% | +3.10% | -7.88% | -115600.00% | -100.09% | +0.09% | +6.50% | n/a | -100.00% | +5.49% | -1.09% | n/a | -100.00% | -0.87% | +9.50% | n/a | -100.00% | n/a |